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Introduction
Multicellular organisms must modulate cellular growth and 
proliferation in response to available nutrients, energy, and 
growth factor signaling. The regulatory kinase target of rapamycin 
(TOR) has emerged as a convergence point for the transduc-
tion of these signals into appropriate changes in cell metabolism 
and growth. TOR activity is stimulated by insulin-responsive 
phosphatidylinositol-3 kinase (PI3K)/Akt signaling, by nutri-
ents such as amino acids, and by high cellular energy levels 
(for reviews see Martin and Hall, 2005; Sarbassov et al., 2005a). 
In response to these signals, TOR effects changes in a diverse 
number of downstream processes, including transcription, 
translation, nutrient import, and autophagy, to achieve the align-
ment of cellular energy utilization with available resources. 
  Unsurprisingly, improper activation of TOR signaling has been 
implicated in the development of cancers and hamartoma syn-
dromes and in metabolic diseases such as diabetes and obesity 
(Manning, 2004). For example, mutations in either component 
of the TSC1–TSC2 complex, which is an upstream inhibitor 
of TOR signaling, result in the formation of benign tumors in 
multiple tissues.
Although TOR is known to affect a wide range of cellular 
processes, the relative contribution of these processes and how 
they interact to result in a directed growth response remain 
poorly understood. Components of the translational machinery 
are well established downstream effectors of TOR signaling 
(Martin and Hall, 2005). TOR directly phosphorylates eukaryotic 
initiation factor-4E–binding protein (4E-BP) and ribosomal pro-
tein S6 kinase (S6K), thereby facilitating cap-dependent transla-
tion and ribosome biogenesis. Although these effects on protein 
synthesis are likely to contribute substantially to cellular growth 
capacity, they are unlikely to fully account for the growth effects 
of TOR. For example, whereas inactivation of TOR results in 
a nearly complete block of protein synthesis in yeast, this effect 
is more modest in mammalian cells, with an  15–50% decrease 
in translation rate (Jefferies et al., 1994; Terada et al., 1994). 
In Drosophila melanogaster, null mutations in 4E-BP are with-
out effect on cell growth (Junger et al., 2003), and the growth 
phenotype of S6k-null mutants is signifi  cantly less severe than 
that of Tor mutants (Montagne et al., 1999; Oldham et al., 2000; 
Zhang et al., 2000). Activation of S6K only partially overcomes 
the growth arrest of Tor mutants in this system. Recent genetic 
studies in mouse have also shown that the ribosomal substrate of 
S6K, rpS6, does not appear to be a relevant mediator of the 
growth effects of this pathway (Pende et al., 2004).
These observations have motivated the search for other 
effector pathways and cellular processes downstream of TOR 
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that might contribute to its effects on cell growth. A growing 
number of studies of TOR structure, function, and localization 
point to an important role for TOR signaling in controlling 
 vesicular  traffi  cking. Biochemical studies in yeast have found 
that TOR localizes to intracellular vesicles and cofractionates 
with endosomal markers (Kunz et al., 2000; Chen and Kaiser, 
2003), which is consistent with a role in the endocytic compart-
ment. In addition, TOR has a highly conserved function as 
a regulator of autophagy, which is a process of cytoplasmic deg-
radation that involves the reorganization of intracellular mem-
branes into autophagic vesicles (Noda and Ohsumi, 1998; Scott 
et al., 2004). Finally, TOR is structurally related to the class III 
PI3K/Vps34 family of lipid kinases, with well characterized 
roles in endocytosis. Interestingly, recent studies have identifi  ed 
a novel role for hVps34 in relaying intracellular nutrient status 
to TOR (Byfi  eld et al., 2005; Nobukuni et al., 2005), indicating 
that this family of molecules may have common roles in nutri-
ent sensing and membrane traffi  cking.
We report the identifi   cation of the clathrin-uncoating 
ATPase Hsc70-4 in a genetic enhancer/suppressor screen for 
novel TOR interactors in D. melanogaster. Hsc70-4 is a critical 
regulator of clathrin-mediated endocytosis, and we provide 
  evidence that TOR signaling infl  uences bulk endocytosis, as 
well as the targeted endocytic degradation of a specifi  c amino 
acid transporter. Our results suggest that TOR controls growth, 
in part, by simultaneously down-regulating aspects of endocy-
tosis that inhibit growth and up-regulating potential growth-
promoting functions of endocytosis.
Results
Hsc70-4 mutants are dominant modiﬁ  ers 
of TOR overexpression phenotypes
To better understand the regulation and downstream effects of 
TOR-mediated growth signaling, we took a genetic approach to 
reveal novel players in the TOR signaling pathway. We used a 
tissue-specifi  c TOR overexpression phenotype as the sensitized 
background for a dominant-modifi  er ethyl methanesulfonate 
(EMS) mutagenesis screen. To create this background, P element–
mediated transposition was used to introduce a copy of the 
wild-type Tor cDNA, which was preceded by multiple copies 
of the eyeless (ey) enhancer, into the D. melanogaster genome. 
ey-driven overexpression of TOR (eyTOR) led to an overall re-
duction in size of the adult eye (Fig. 1, A–B), demonstrating the 
paradoxical decrease in growth previously observed to result 
from wild-type TOR overexpression (Hennig and Neufeld, 
2002). In addition to the reduction in eye size, ommatidial 
  patterning was disorganized, with some ommatidia appearing 
fused or pitted. Immunohistochemistry of eyTOR imaginal 
discs revealed a delay in morphogenetic furrow progression and 
missing and disorganized photoreceptor cells, as well as an in-
creased level of cell death (Fig. S1, available at http://www/jcb.
org/cgi/content/full/jcb.200511140/DC1). The severity of the 
eyTOR phenotype was strongly enhanced by a heterozygous-
null mutation of the negative TOR regulator Tsc1 (Fig. 1 C) and 
was suppressed by addition of rapamycin to the media (Fig. S1). 
These results suggest that the eyTOR phenotype results from 
inappropriately high levels of TOR signaling, and they demon-
strate the potential utility of this overexpression phenotype as 
a dosage-sensitive genetic background.
We next sought to identify novel factors involved in 
TOR signaling by screening for the ability of EMS-generated 
  mutations to dominantly modify the eyTOR phenotype. From 
 60,000 F1 progeny scored, we identifi  ed 23 eyTOR enhancers 
and 2 suppressors. Within this collection were two independent 
groups that failed to complement for lethality. We report the 
analysis of a third chromosome complementation group consist-
ing of two alleles (e3 and e19) isolated as dominant enhancers 
of the eyTOR phenotype. Heterozygous mutation of either e3 
or e19 caused a further reduction in eye size of eyTOR fl  ies 
(Fig. 1 D and Fig. S1) and a similar enhancement of MS1096-
Gal4-driven TOR misexpression phenotypes in the adult wing 
(Fig. S1). Through recombination and defi  ciency mapping we 
localized the e3 and e19 mutations to the 88E4 genomic region. 
Complementation tests with lethal mutations in this interval re-
vealed that e3 and e19 disrupt the Hsc70-4 gene, which encodes 
a constitutively expressed member of the stress-induced Hsp70 
family of ATPases. Independently isolated mutant alleles of 
Hsc70-4 also displayed a strong enhancement of the eyTOR 
phenotype (Fig. S1). In addition, both the dominant eyTOR 
  enhancement and the recessive lethality of e3 and e19 could be 
rescued by a transgene carrying a wild-type copy of Hsc70-4 
(Hing et al., 1999; Fig. S1). We found that the e3 and e19 muta-
tions result in single amino acid substitutions within the ATPase 
domain of Hsc70-4 (Ser40 to Phe and Arg301 to Cys, respectively; 
Fig. 1 G). These residues are completely conserved in fungi, 
plant, and animal Hsc70-4 orthologues, indicating their likely 
importance for Hsc70-4 function. Therefore, from this point 
forth we refer to these mutations as Hsc70-4
e3 and -4
e19.
Hsc70-4 catalyzes the uncoating of clathrin-coated vesi-
cles, which is an essential late step in clathrin-mediated 
  en  docytosis (Schlossman et al., 1984; Chang et al., 2002). 
In addition, Hsp70 family members can act as chaperones 
to regulate protein folding and stability (Mayer and Bukau, 
2005). To determine whether either of these functions of 
Hsc70-4 contributes to its genetic interactions with TOR, we 
fi  rst assayed the ability of other endocytic factors to modify 
TOR misexpression phenotypes. Shibire (shi) encodes the 
D. melanogaster homologue of dynamin, which is a GTPase 
critical for the proper membrane closure and budding of endo-
cytic vesicles from the plasma membrane (Chen et al., 1991). 
We found that expression of a dominant-negative form of 
 shibire,  Shi
K44A (Moline et al., 1999), strongly enhanced the 
eyTOR phenotype (Fig. 1, E and F), suggesting that Hsc70-4 
may infl  uence TOR signaling through its role in endocytosis. 
In contrast, Hsc70-4 mutations did not lead to increased levels 
of TOR protein in   eyTOR eye imaginal discs (Fig. 1 H), indi-
cating that the enhancement of the eyTOR phenotype by 
Hsc70-4 mutants is not caused by increased stability or abun-
dance of overexpressed TOR protein. We also observed no in-
crease in total levels of endogenous TOR protein in Hsc70-4 
mutants (Fig. 1 I). Interestingly, we found that expression of 
Shi
K44A led to increased localization of TOR to vesicular struc-
tures, a subset of which were accessible to an endocytic tracer TOR REGULATES ENDOCYTOSIS TO EFFECT CELL GROWTH • HENNIG ET AL. 965
(Fig. 1, J–L; see below), further supporting a link between 
TOR signaling and endocytosis.
TOR signaling promotes bulk endocytosis
To further characterize the interplay between TOR and endocy-
tosis, we tested the effect of TOR signaling on several endocytic 
markers in the D. melanogaster larval fat body. The fat body 
serves as a nutrient storage organ that is analogous to the verte-
brate liver (Dean et al., 1985), and it has recently been shown 
to act as a nutrient sensor capable of affecting global growth 
through a TOR-dependent humoral mechanism (Colombani 
et al., 2003). We tested the effects of altered nutrient availability 
and TOR signaling on the intracellular localization of compo-
nents of the endocytic machinery, using GFP-fusions to Rab5, 
Rab7, and clathrin. In fat body cells from fed control animals, 
we observed GFP-Rab5 localization both at the cell surface and 
throughout the cytoplasm (Fig. 2 A).  In contrast, larvae sub-
jected to a 5-h starvation displayed a variable redistribution of 
GFP-Rab5 toward the cell surface, with a less diffuse, punctate 
pattern often observed in these cells (Fig. 2 B). More direct 
  alteration of TOR signaling, through overexpression of TSC1 
and TSC2, or TOR itself, also affected GFP-Rab5 localization, 
resulting in the appearance of large aggregates near the cell sur-
face (Fig. 2 C). The localization of GFP-Rab7 and clathrin-GFP 
was also altered in response to TOR inhibition (unpublished 
data). Overexpression of TOR in fat body cells also resulted 
in increased expression of Hsc70-4, as monitored by a GFP-
Hsc70-4 fusion expressed from the endogenous Hsc70-4 locus 
(Clyne et al., 2003). Together, these data indicate that altered 
TOR signaling effects an endocytic response in the fat body.
To better understand the nature of these endocytic changes, 
we monitored the effects of TOR signaling on the ability of fat 
Figure 1.  Mutations in endocytic regulators modify TOR overexpression phenotypes. (A–F) Disruption of Hsc70-4 or shibire dominantly enhances the 
small rough eye phenotype caused by ey TOR. Scanning electron microscopy images of D. melanogaster compound eyes: wild-type (A), eyTOR/+ 
(B),   eyTOR/+; Tsc1
29/+ (C), eyTOR/+; Hsc70-4
e19/+ (D), UAS-Shi
K44A/+; eyGAL4/UAS-Shi
K44A (E), and UAS-Shi
K44A/+; eyTOR eyGAL4/UAS-Shi
K44A (F). 
(G) Mutations in the e3/e19 complementation group disrupt the ATPase domain of the Hsc70-4 clathrin-uncoating ATPase. Shown is the domain structure of 
Hsc70-4, with the mutated residues indicated. (H and I) Mutation of Hsc70-4 does not lead to increased levels of TOR protein. (H) Loss of GFP   expression 
marks a clone of cells homozygous for Hsc70-4
e3 (arrow) from an eye imaginal disc expressing eyeless-driven FLAG-tagged TOR. Genotype:   hsﬂ  p
122/+; 
  eyTOR/+; FRT82B Ubi-GFP/FRT82B Hsc70-4
e3. (I) Extracts from wild-type and Hsc70-4
e3/e19 third instar larvae were blotted with anti-TOR antibodies to 
  detect endogenous TOR levels. (J–L) Expression of Shi
K44A causes relocalization of TOR to endocytic vesicles. FLAG-tagged TOR expressed clonally in fat body 
cells (J) shows altered distribution upon coexpression of UAS-Shi
K44A (K). TOR-containing vesicles near the cell surface can incorporate the endocytic tracer TR-avidin 
(L, arrow). Genotype: hsﬂ  p
122/+; Act>CD2>Gal4, UAS-TOR/TM3-UAS-Shi
K44A. Bars: (A–F) 100 μm; bar in (L) is 12.5 μm in H–K, and 6.25 μm in L.JCB • VOLUME 173 • NUMBER 6 • 2006  966
body cells to internalize a fl  uorescent endocytic tracer, Texas 
red–conjugated avidin (TR-avidin). In control experiments 
we found that genetic disruption of shi or Hsc70-4 prevented 
proper endocytic uptake in these cells, as was demonstrated 
  previously in Garland cells (Kosaka and Ikeda, 1983; Chang 
et al., 2002). TR-avidin failed to be effi  ciently internalized in 
Shi
K44A-expressing fat body cells, and instead accumulated near 
the cell surface, often in large aggregates (Fig. 2 E). TR-avidin 
uptake was also blocked in cells that were homozygous for a null 
allele of Hsc70-4 (Bronk et al., 2001), and, in this case, a decrease in 
both surface-bound and internalized tracer was observed (Fig. 2 F).
A similar, but less extensive, decrease in TR-avidin uptake was 
observed in Hsc70-4
e3 and -4
e19 mutant cells (Fig. S2, available 
at http://www/jcb.org/cgi/content/full/jcb.200511140/DC1).
We next used this assay to monitor the effects of altered 
TOR signaling on bulk endocytic uptake. Mosaic clones mutant 
for a null allele of Tor showed a nearly complete block of 
TR-avidin uptake (Fig. 2 G). Similar effects were observed 
when TOR signaling was inhibited by overexpression of TSC1–
TSC2 or TOR (Fig. S2). To see whether increased activation 
of TOR could further stimulate endocytic internalization, we 
generated mitotic clones homozygous for a Tsc1-null allele. 
  Increased tracer uptake was observed in these cells (Fig. 2 H). 
Overexpression of Rheb, which is an upstream activator of 
TOR, caused a similar increase in TR-avidin uptake (Fig. S2). 
We also tested whether two targets of TOR, S6K and 4E-BP, 
  affected endocytosis. Cells mutant for a null allele of S6k 
showed a strong decrease in TR-avidin uptake, suggesting that 
the   effects of TOR on endocytosis are mediated in large part 
through S6K (Fig. 2 I). In contrast, overexpression of 4E-BP, whose 
activity is inhibited by TOR, had no effect in this assay (Fig. 2 J).
As an alternative approach to monitoring endocytosis 
in vivo, we tested the ability of fat body cells to internalize larval 
serum protein 2 (Lsp2). Lsp2 is present in the hemolymph 
Figure 2.  TOR signaling affects endocytosis. (A–C) Starvation and TOR overexpression affect GFP-Rab5 localization. Flp-dependent, spontaneously 
  induced clones of GFP-Rab5–expressing cells in mid–third instar fat body tissue are shown. (A) Under fed conditions, GFP-Rab5 is uniformly distributed 
throughout both the cytoplasm and surface of these cells. (B) In larvae starved for 4.5 h, higher levels of GFP-Rab5 are observed near the cell surface. 
(C) TOR overexpression leads to the formation of large GFP-Rab5 aggregates at the cell surface. Images in A–C show the nuclear focal plane. Inset in C 
shows image taken at a focal plane just below the plasma membrane. Genotypes: hsﬂ  p
122/+; Act>CD2>Gal4/UAS-GFP-Rab5 (A and B) and hsﬂ  p
122/+; 
UAS-TOR, Act>CD2>Gal4/UAS-GFP-Rab5 (C). (D) TOR overexpression increases levels of GFP-Hsc70-4. The image shows a clone of cells expressing 
FLAG-tagged TOR (marked by FLAG staining in inset), resulting in increased levels of endogenously expressed GFP-Hsc70-4. Genotype: hsﬂ  p
122/+; UAS-
TOR, Act>CD2>Gal4/Hsc70-4
Wee-P1. (E–J) Endocytic uptake in D. melanogaster fat body cells. Fat body tissue containing clones of overexpressing or 
  mutant cells was incubated with ﬂ  uorescently labeled avidin to monitor endocytic uptake. Images show surface (E and F) or cytoplasmic (E’, F’, and G–J) 
  focal planes. Clones are demarcated by GFP expression (insets) and are indicated by yellow arrows. (E–F) Endocytosis is inhibited in response to disruption 
of shibire or Hsc70-4 function. A clone of Shi
K44A-expressing cells (E) is marked by GFP expression, and a clone homozygous mutant for a null allele of 
Hsc70-4 (F) is marked by the absence of GFP. (G–J) TOR signaling positively affects bulk endocytic uptake. Shown are clones of cells homozygous for null 
mutations in Tor (G), Tsc1, (H), S6k (I), and a clone overexpressing 4E-BP (J). Bar, 25 μm. Genotypes: hsﬂ  p
122/+; Act>CD2>Gal4, UAS-GFP/TM3-UAS-
Shi
K44A (E), hsﬂ  p
122/+; Cg-Gal4/+; FRT82B UAS-GFP/FRT82B Hsc70-4
∆16 (F), hsﬂ  p
122/+; UAS-2XeGFP FRT40A fb-GAL4/Tor
∆P FRT40A (G), hsﬂ  p
122/+; 
Cg-Gal4/+; FRT82B UAS-GFPnls/FRT82B Tsc1
29 (H), hsﬂ  p
122/+; Cg-Gal4/+; UAS-2XeGFP FRT80B/S6K
l1 FRT80B (I), and hsﬂ  p
122/+; Act>CD2>Gal4, 
UAS-GFP/UAS-4E-BP (J). Bar, 25 μm.TOR REGULATES ENDOCYTOSIS TO EFFECT CELL GROWTH • HENNIG ET AL. 967
  during larval development, and is internalized through endocy-
tosis by the fat body during the late third instar period (Levenbook, 
1985). Anti-Lsp2 staining revealed a fi  ne punctate appearance 
throughout the cytoplasm of wild-type cells (Fig. 3). In contrast, 
Shi
K44A-expressing cells displayed large aggregates of Lsp2 
 protein at the cell surface and an absence of internal Lsp2 staining 
(Fig. 3 A). Hsc70-4 mutant cells were also defective in Lsp2 
uptake, and, again, differed from Shi
K44A-expressing cells in 
showing a decrease in Lsp2, both internally and at the surface 
(Fig. 3 B). The effects of TOR signaling on Lsp2 internalization 
were identical to the effects on TR-avidin; Lsp2 uptake was se-
verely reduced in Tor or S6k mutant cells and in TSC1–TSC2–
overexpressing cells, and was increased in cells mutant for Tsc1 
or overexpressing Rheb (Fig. 3, C–E, and Fig. S2). Together, 
these results demonstrate that the Rheb–TOR–S6K pathway is 
required for proper endocytic uptake and indicate a novel role for 
TOR signaling in the positive stimulation of bulk endocytosis. 
Furthermore, they indicate that Shi
K44A expression and loss of 
Hsc70-4 result in distinct endocytic phenotypes in the fat body.
TOR signaling inhibits the endocytic 
degradation of Slimfast
In addition to the nonselective endocytic uptake described in the 
previous section, studies in yeast and cultured mammalian cells 
have shown that TOR can selectively infl  uence the endocytic 
uptake and degradation of specifi  c nutrient transporters (Beck 
et al., 1999; Edinger and Thompson, 2002). To investigate the 
effects of TOR signaling on targeted endocytosis, we generated 
an antibody to Slimfast, which is a cationic amino acid importer 
previously shown to positively affect organismal growth through 
effects on the TOR and PI3K signaling pathways (Colombani 
et al., 2003). We used this antibody to test whether TOR signal-
ing may regulate the endocytic turnover of Slimfast in response 
to nutrient conditions. Antibody staining of fat body tissue 
 confi  rmed that Slimfast is localized primarily to the cell surface, 
with peak levels just below the plasma membrane (Fig. 4 
and Fig. S3, available at http://www/jcb.org/cgi/content/full/
jcb.200511140/DC1). Disruption of endocytosis through Shi
K44A 
expression resulted in a marked increase in Slimfast at the cell 
surface (Fig. 4 A), suggesting that endocytosis normally acts 
to antagonize the surface expression of Slimfast. In contrast, 
 disruption  of  Hsc70-4 did not lead to increased surface levels 
of Slimfast (Fig. 4, B and C), which is consistent with 
the   distinct effects of Shi
K44A and Hsc70-4 mutants on bulk 
 endocytic  uptake.
We next asked whether changes in TOR signaling affect 
Slimfast levels. Activation of TOR through clonal overexpres-
sion of Rheb caused an increase in surface levels of Slimfast, 
which was similar to the effects of Shi
K44A (Fig. 4 D). The rela-
tive effect of Rheb on Slimfast levels was especially pronounced 
in larvae subjected to a 24-h starvation (Fig. S3). Under these 
conditions, TOR activity is reduced in wild-type cells, but main-
tained in Rheb-overexpressing cells (Saucedo et al., 2003). 
To test whether Slimfast up-regulation is simply caused by 
  increased protein synthesis in Rheb-overexpressing cells, we 
added the translation inhibitor cycloheximide during the 24-h 
starvation period. Under these conditions, Rheb overexpression 
still led to a modest relative increase in Slimfast levels (Fig. S3), 
which was consistent with a partial posttranslational effect. 
  Reduction in TOR signaling also had a marked effect on Slim-
fast staining, as overexpression of TSC1–TSC2 led to a decrease 
in Slimfast levels (Fig. 4 E). Thus, the localization and levels 
of Slimfast are sensitive to TOR activity, with high levels of 
TOR signaling resulting in accumulation of Slimfast near the 
cell   surface, and decreased TOR signaling leading to Slimfast 
down-regulation.
We next sought to determine whether TOR signaling 
might mediate these changes in Slimfast levels through effects 
on the targeted endocytosis of this importer. We tested whether 
the Slimfast down-regulation that results from TSC1–TSC2 
Figure 3.  Endocytic regulators and TOR signaling control Lsp2 internal-
ization. Images show surface (A and B) or cytoplasmic (A’, B’, and C–F) 
  focal planes of third instar larval fat body stained with anti-Lsp2. (A and B) 
Endocytosis of Lsp2 from the larval hemolymph is inhibited in response to 
disruption of shibire (A) or Hsc70-4 (B). Note the accumulation of Lsp2 at 
the surface of Shi
K44A-expressing cells, but not in Hsc70-4–null cells. (C–F) 
TOR signaling is required for Lsp2 uptake. Shown are clones of cells homo-
zygous for null mutations in Tor (C), Tsc1 (D), S6k (E), and a clone over-
expressing 4E-BP (F). Arrows indicate mutant or overexpressing cells. 
Bar, 25 μm. Genotypes are as in Fig. 2 E–J.JCB • VOLUME 173 • NUMBER 6 • 2006  968
overexpression requires endocytosis by cooverexpressing 
TSC1–TSC2 and Shi
K44A. In the absence of functional endocy-
tosis, TSC1–TSC2 overexpression no longer led to Slimfast 
down-regulation. Instead, Slimfast protein appeared to be 
trapped in large aggregates near the surface of these cells (Fig. 
4 F). Similar results were observed when TOR activity was 
  inhibited through starvation. In well fed larvae, partial disrup-
tion of endocytosis through expression of dominant-negative 
Rab5
S43N had little effect on Slimfast levels (Fig. 4 G). In con-
trast, Rab5
S43N expression led to a marked persistence of Slim-
fast at the plasma membrane in starved larvae (Fig. 4 H). 
Collectively, these results demonstrate that endocytosis is criti-
cal for Slimfast down-regulation in response to reduced TOR 
signaling, resulting either from poor nutrient conditions or inac-
tivation by the TSC1–TSC2 complex.
To further investigate whether the endocytic down-regula-
tion of Slimfast is a specifi  c, targeted process, we examined 
the effects of altering components of the endocytic sorting/ 
targeting machinery on Slimfast levels. Hrs (hepatocyte growth 
factor–regulated tyrosine kinase substrate) is an early endosome–
associated, ubiquitin-binding protein that is critical for proper 
endocytic sorting. As shown in Fig. 4 I, homozygous mutation 
of Hrs led to a marked increase in Slimfast levels near the cell 
surface. Expression of a dominant-negative version of Nedd4, 
which is an E3 ubiquitin ligase, similarly caused persistence of 
Slimfast near the cell periphery (Fig. 4 J). Monoubiquitination 
by the Nedd4 family of enzymes is critical for the initial target-
ing of plasma membrane–localized proteins to clathrin-coated 
pits for internalization (Rotin et al., 2000). Together, these 
  results demonstrate that components of the endocytic targeting/
sorting machinery are critical in mediating Slimfast turnover.
Endocytosis affects cell growth
Our observations indicate that TOR signaling affects both bulk 
and targeted endocytosis. Interestingly, we note that TOR ap-
pears to exert opposing effects on these processes, stimulating 
bulk endocytosis (Figs. 2 and 3) and inhibiting the targeted en-
docytic degradation of Slimfast (Fig. 4). To test whether TOR’s 
effects on endocytosis might contribute to its role in promoting 
cell growth, we assayed the growth properties of cells in which 
endocytosis was disrupted. Flow cytometric analysis of mosaic 
wing imaginal discs revealed an increased cell size and  increased 
G2 population in Hsc70-4
e3 and -4
∆16 mutant cells, relative to 
wild-type cells (Fig. 5, B and C).  These effects were acutely 
dosage-sensitive, as Hsc70-4 heterozygous cells were also 
larger than wild type (Fig S4). Expression of Shi
K44A or of 
a dominant-negative Hsc70-4
K71S transgene also resulted in in-
creased cell size (Fig. 5, E and F). This cytometric profi  le of in-
creased cell size and G2 content is similar to that of mutations 
Figure 4.  TOR signaling inhibits endocytic down-regulation of the amino 
acid transporter Slimfast. Fat body tissue from mid–third instar larvae 
stained with Slimfast antibody, which is shown in red. Nuclei are shown in 
blue. Insets show cellular genotypes; transgene-expressing clones (A, D–H, 
and J) are marked by GFP expression (green) and loss-of-function clones 
(B, C, and I) are marked by the absence of GFP. (A–C) High levels of Slim-
fast accumulate near the surface of cells expressing Shi
K44A (A), but not in 
cells homozygous for two different alleles of Hsc70-4 (B and C). Mutant 
cells are indicated by arrows. (D and E) Slimfast levels are regulated by 
TOR signaling. (D) Overexpression of the positive TOR regulator Rheb 
leads to increased cell surface levels of Slimfast. (E) Overexpression of the 
negative TOR regulators Tsc1 and Tsc2 leads to decreased Slimfast levels. 
(F–H) Slimfast down-regulation resulting from TOR inactivation requires 
  endocytosis. Coexpression of Shi
K44A inhibits TSC1–TSC2-induced Slimfast 
down-regulation (F; compare to E). Expression of dominant-negative 
Rab
S43N does not affect Slimfast levels in fed animals (G), but prevents Slim-
fast down-regulation in response to 24-h starvation (H). (I and J) Slimfast 
turnover requires endocytic targeting/sorting factors. Loss of Hrs function (I) 
or expression of dominant-negative Nedd4 (J) leads to increased Slimfast 
at the plasma membrane. Slimfast is imaged just below the plasma mem-
brane focal plane in these images; GFP expression in insets is imaged 
at the nuclear focal plane. Arrows mark mutant cells. Genotypes: 
hsﬂ  p
122/+; Act>CD2>Gal4, UAS-GFP/UAS-Shi
K44A (A), hsﬂ  p
122/+; Cg-
Gal4/+; FRT82B UAS-GFP/FRT82B Hsc70-4
e3 (B), hsﬂ  p
122/+; Cg-Gal4/+; 
FRT82B UAS-GFP/FRT82B Hsc70-4
∆16 (C), hsﬂ  p
122/+; Act>CD2>Gal4, 
UAS-GFP/UAS-Rheb
EP50.084 (C and D), hsﬂ  p
122/+; Act>CD2>Gal4, 
UAS-GFP/UAS-Tsc1, UAS-Tsc2, (F) hsﬂ  p
122/+; Tubulin>CD2>Gal4, UAS-
GFP/+; TM3-UAS-Shi
K44A/UAS-Tsc1, UAS-Tsc2 (E), hsﬂ  p
122/+; 
Act>CD2>Gal4, UAS-GFP/UAS-Rab5
S43N (G and H), hsﬂ  p122/+; Hrs
D28 
FRT40A/UAS-2XeGFP FRT40A fb-Gal4 (I), and hsﬂ  p
122/+; 
Act>CD2>Gal4, UAS-GFP/UAS-Nedd4
C97411S (J). Bar, 25 μm.TOR REGULATES ENDOCYTOSIS TO EFFECT CELL GROWTH • HENNIG ET AL. 969
in negative regulators of TOR such as Tsc1, Tsc2, and Pten 
(Gao et al., 2000; Gao and Pan, 2001), and to that of cells over-
expressing Rheb (Saucedo et al., 2003).
Disruption of endocytosis also led to dosage-dependent 
cell size changes in the fat body. Expression of Shi
K44A caused 
a 1.5-fold increase in fat body cell size (Fig. 5, I and J), which 
is consistent with its growth effects in wing disc cells. In con-
trast, cells homozygous for mutant alleles of Hsc70-4 showed 
either a slight (e3) or a threefold decrease in cell size (∆16 null; 
Fig. 5, G, H, and J). Given that Shi
K44A expression and Hsc70-4 
mutation result in a similar block of endocytic uptake, but show 
distinct effects on Slimfast expression, these results suggest   
that the relative contributions to growth of bulk and transporter-
  mediated nutrient uptake may differ between imaginal disc and 
fat body cells.
Together, the fi  nding that endocytosis is both regulated 
by TOR and has effects on cell growth indicates that endocy-
tosis functions as a downstream effector of TOR signaling. TOR 
  simultaneously down-regulates aspects of endocytosis that 
  inhibit growth and up-regulates potential growth-promoting 
functions of endocytosis.
Endocytosis affects TOR signaling
In addition to acting downstream of TOR, the potential role 
of endocytosis in controlling nutrient import suggested that 
it might also function upstream to regulate TOR activity, 
which is stimulated by nutrients in general and Slimfast 
in parti  cular (Colombani et al., 2003). Endocytosis has also 
been shown to affect the levels and activity of the insulin 
  receptor (Ceresa et al., 1998), which may function upstream 
of TOR by activating PI3K signaling (Inoki et al., 2002). 
  Indeed, we observed an increase in insulin receptor levels 
similar to that of Slimfast in response to Rheb overexpres-
sion (Fig. S3). Therefore, we examined the effects of endocy-
tosis on in vivo markers of PI3K and TOR activity. To test 
whether endocytosis infl  uences PI3K signaling, we analyzed 
the effects of Shi
K44A expression on the transcription factor 
FOXO, which is excluded from the nucleus in response 
to PI3K-dependent phosphorylation (Brunet et al., 1999). 
Clonal expression of Shi
K44A in fat body cells resulted in 
  relocalization of FOXO from the nucleus to the cytoplasm 
(Fig. 6 A), refl  ecting increased PI3K activity and, thus, indi-
cating that endocytosis normally exerts a negative effect on 
PI3K signaling in these cells. 
As a cellular readout of TOR signaling, we monitored 
the effects of endocytosis on autophagy, which is a process of 
cytoplasmic degradation that is inhibited by TOR (Noda and 
Ohsumi, 1998; Scott et al., 2004). Disruption of endocytosis 
through expression of Shi
K44A prevented proper induction of 
  autophagy after starvation (Fig. 6 B), which is indicative of high 
levels of TOR signaling in these cells. A similar inhibition of 
autophagy was observed in Hsc70-4-null cells and in cells 
Figure 5.  Inhibition of endocytosis leads to tissue-  speciﬁ  c 
effects on cell growth. (A–F) Disruption of Hsc70-4 or shibire 
function in imaginal disc cells causes increased cell size 
and G2 population. Graphs show ﬂ  ow cytometric analy-
sis of dissociated wing imaginal discs containing clones 
of  Hsc70-4 mutant cells (B and C) or cells expressing 
dominant-negative Hsc70-4 or shibire (E and F). Histo-
grams show DNA content (left) and forward light scatter 
(right; indicative of cell size). In (A-C) red traces represent 
GFP-negative Hsc70-4 mutant or control cell populations, 
and green traces represent GFP-positive wild-type cell 
populations. In D–F, green traces represent GFP-positive 
transgene-expressing cells and red traces represent 
GFP-negative wild-type cells. Genotypes: hsﬂ  p
122/+; FRT82B 
Ubi-GFP/FRT82B (A), hsﬂ  p
122/+; FRT82B Ubi-GFP/
FRT82B Hsc70-4
e19 (B), hsﬂ  p
122/+; FRT82B Ubi-GFP/
FRT82B Hsc70-4
∆16 (C), hsﬂ  p
122/+; Act>CD2>Gal4, 
UAS-GFP/+ (D), hsﬂ  p
122/+; UAS-Hsc70-4
K71S/+; 
Act>CD2>Gal4, UAS-GFP/+ (E), hsﬂ  p
122/UAS-Shi
K44A; 
UAS-Shi
K44A/+; Act>CD2>Gal4, UAS-GFP/+ (F). (G–I) 
Hsc70-4 mutation and Shi
K44A expression cause distinct 
effects on fat body cell size. Clones of Hsc70-4 mutant cells 
(G and H; GFP-negative cells marked by arrows) or 
Shi
K44A   expressing cells (I; GFP-positive cells) are shown. 
Cell outlines are marked by phalloidin staining (red). 
  Genotypes: hsﬂ  p
122/+; Cg-Gal4/+; FRT82B UAS-GFP/
FRT82B Hsc70-4
e3 (G), hsﬂ  p
122/+; Cg-Gal4/+; FRT82B 
UAS-GFP/FRT82B Hsc70-4
∆16 (H), hsﬂ  p
122/+; 
Act>CD2>Gal4, UAS-GFP/TM3-UAS-Shi
K44A (I). Bar, 
25  μm. (J) Quantitation of fat body cell size data. 
Shown are area measurements of cells homozygous for 
Hsc70-4
e3 or Hsc70-4
∆16, or expressing Shi
K44A, relative 
to surrounding wild-type cells. Error bars indicate the 
SEM. Number of cells scored are as follows: Hsc70-4
e3, 
n  = 116 (27 mutant and 89 wild type); Hsc70-4
∆16, 
n = 109 (22 mutant and 87 wild type); Shi
K44A, n = 175 
(24 transgene-  expressing and 151 wild type).JCB • VOLUME 173 • NUMBER 6 • 2006  970
  expressing dominant-negative Hsc70-4
K71S (Fig. S4, available 
at http://www/jcb.org/cgi/content/full/jcb.200511140/DC1).
To assess the effects of endocytosis on the kinase activity 
of TOR, we monitored the levels and the phosphorylation status 
of known TOR substrates. Inactivation of D. melanogaster TOR 
through mutation or starvation has previously been shown to 
cause a decrease in S6K phosphorylation at Thr398, as well as 
an increase in S6K protein levels, through an unknown mecha-
nism (Oldham et al., 2000; Gao et al., 2002). More recently Akt 
(Ser505) has been identifi  ed as a substrate for TOR in associa-
tion with its cofactor rictor (Sarbassov et al., 2005b). Accord-
ingly, in control experiments we found that Tsc1
29 homozygous 
larvae showed a decrease in total S6K levels and a slight de-
crease in Thr398 phosphorylation relative to wild-type controls 
(Fig. 6 C); normalized for S6K levels, Thr398 phosphorylation 
was increased as expected. Tsc1
29 mutant larvae also showed 
a strong loss of Akt-Ser505 phosphorylation, which is consis-
tent with recent studies showing that the TSC1–TSC2 complex 
promotes TOR–rictor signaling to Akt (Yang et al., 2006). 
We next examined these markers in extracts from Hsc70-4
e3/e19 
transheterozygous mutants, which are viable through the third 
instar larval stage. Similar to Tsc1
29 mutants, Hsc70-4
e3/e19 larvae 
showed a decrease in overall S6K levels and a reduction in S6K 
and Akt phosphorylation; in this case, Thr398 phosphorylation 
relative to S6K abundance was reduced compared with wild 
type (Fig. 6 C).
The similarity between Hsc70-4 and Tsc1 mutants was 
further underscored through chemical and genetic interaction 
studies. Imaginal disc cells doubly mutant for Hsc70-4
e3 and 
Tsc1
29 showed a synergistic increase in cell size as compared 
with their single mutant counterparts (Fig. 6 D). Similarly,  using 
the ey-FLP system to generate homozygous mutant eye tissue, 
we observed an exacerbation of Tsc1
29-induced tissue over-
growth in the presence of Hsc70-4
e3 mutation, in some cases 
  resulting in a marked outgrowth of tissue in the anterior portion 
of the retina (Fig. 6 E). We also tested whether mutation of 
Hsc70-4 affects sensitivity to rapamycin, which inhibits TOR 
signaling through the formation of an inhibitory binding com-
plex with the intracellular protein FKBP12 (Brown et al., 1994; 
Sabatini et al., 1994). Growth of wild-type D. melanogaster is 
delayed on media containing rapamycin, and this delay is sensi-
tive to the dosage of TOR pathway genes (Zhang et al., 2000; 
Patel et al., 2003). We found that heterozygous Hsc70-4
e3 muta-
tion signifi  cantly alleviated the rapamycin-induced delay (Fig. 
6 F), which is consistent with increased levels of TOR signal-
ing. Collectively, the cellular, biochemical, and genetic effects 
of endocytosis are consistent with this process playing a signifi  -
cant role in cell growth and TOR signaling.
Discussion
Inactivation of TOR causes an inhibition of cellular growth, 
a reduction in cell size, and a suppression of cell cycle progres-
sion. In addition to well described changes in protein synthesis 
and ribosome biogenesis, recent studies have suggested that 
other cell processes are likely to contribute to these growth 
Figure 6. Endocytosis regulates growth signaling. 
(A and B) Inhibition of shibire increases PI3K signaling 
and inhibits autophagy. (A) Antibody staining shows 
  increased cytoplasmic localization of the transcription 
factor FOXO in Shi
K44A-expressing clones. (B) Induction 
of autophagy by 5 h starvation is blocked in Shi
K44A-
expressing clones. Autophagic cells are indicated by 
the punctate staining of LysoTracker red. Genotype: 
  hsﬂ  p
122/+; Act>CD2>Gal4, UAS-GFP/UAS-Shi
K44A. (C) 
Immunoblot showing levels and phosphorylation status of 
S6K and AKT from control (lane 1), Hsc70-4
e3/e19 (lane 
2), and Tsc1
29 (lane 3) larval extracts. (D) Hsc70-4 muta-
tion increases the severity of Tsc1 cell size and cell cycle 
  phenotypes. Flow cytometric histograms of Hsc70-4
e3 and 
Tsc1
29 single- and double-mutant mitotic clones are shown. 
  Genotypes: (Row 1) hsﬂ  p
122/+; FRT82B Ubi-GFP/FRT82B 
Hsc70-4
e3, (Row 2) hsﬂ  p
122/+; FRT82B Ubi-GFP/FRT82B 
Tsc1
29, (Row 3) hsﬂ  p
122/+; FRT82B Ubi-GFP/FRT82B 
Tsc1
29 Hsc70-4
e3. (E) Hsc70-4 and Tsc1 mutants show syn-
ergistic effects on tissue growth. Shown are eyes contain-
ing eye-speciﬁ  c clones homozygous   mutant for Hsc70-4 
(top),  Tsc1 (middle), or Hsc70-4 and Tsc1 (bottom). 
Mutant clones are marked by the lack of the white
+ marker, 
and thus appear white. Note the loss of anterior tissue 
in Hsc70-4 mutant eyes (top, arrow) and the overgrowth 
of anterior tissue in Hsc70-4 Tsc1 double mutants (bottom, 
arrow). Genotypes: ey-FLP/+; FRT82B Pw
+ l(3)cl
R3/FRT82B 
Hsc70-4
e3 (top), ey-FLP/+; FRT82B Pw
+ l(3)cl
R3/FRT82B 
Tsc1
29 (middle), ey-FLP/+; FRT82B Pw
+ l(3)cl
R3/FRT82B 
Hsc70-4
e3 Tsc1
29 (bottom). (F) Heterozygous mutation of 
Hsc70-4 dominantly confers rapamycin resistance. 
Wild-type and Hsc70-4
e3/+ animals develop at a similar 
rate to adulthood (eclosion) when grown on normal media. 
Addition of rapamycin to the media results in a more 
  severe delay in wild type than in Hsc70-4
e3/+ animals. 
Bar in B is 25 μm in A, 50 μm in B, and 200 μm in E.TOR REGULATES ENDOCYTOSIS TO EFFECT CELL GROWTH • HENNIG ET AL. 971
  effects of TOR. The present study identifi  es endocytosis as one 
such process. Our results demonstrate that the clathrin-uncoating 
ATPase Hsc70-4 interacts genetically with TOR and Tsc1, and 
that bulk endocytosis is stimulated in cells with activated TOR 
signaling. Conversely, we fi  nd that TOR activity inhibits the 
endocytic degradation of nutrient transporters such as Slimfast. 
Together, these endocytic effects of TOR promote both the bulk 
and targeted uptake of nutrients and other biomolecules  required 
for cell mass increase (Fig. 7). In addition to this direct role in 
cellular biosynthesis and growth, nutrients also act as potent 
regulators of TOR signaling. Indeed, Slimfast was previously 
identifi  ed as an upstream activator of TOR (Colombani et al., 
2003). Our fi  ndings that disruption of endocytosis effects cell 
size, rapamycin sensitivity, and TOR kinase activity are consis-
tent with an additional role for endocytosis upstream of TOR.
Mutations that disrupt endocytosis are likely to have both 
positive and negative effects on nutrient uptake and cell growth 
because they inhibit bulk endocytic uptake, as well as degrada-
tion of nutrient transporters and other signaling molecules. Thus, 
the overall effects of endocytic disruption on nutrient uptake, cell 
growth, and TOR signaling are diffi  cult to predict a priori. Our 
results suggest that both the cellular context and the specifi  c step 
at which endocytosis is blocked infl  uence the growth   response. 
Thus, in fat body cells, expression of Shi
K44A resulted in an in-
crease in cell size, whereas loss of Hsc70-4 function caused 
reduced cell size. We note that these changes mirror the effects 
of these mutations on Slimfast levels; whereas both Shi
K44A 
 expression  and  Hsc70-4 mutation decreased bulk endocytic up-
take, only Shi
K44A resulted in increased levels of Slimfast. In con-
trast, both Shi
K44A and Hsc70-4 mutants led to the increased size 
of wing imaginal disc cells, suggesting that in these cells the 
growth-inhibitory effects of endocytic degradation of membrane 
proteins such as Slimfast predominate over the potential positive 
effects of increased bulk uptake. Similarly, our results indicate 
a complex effect of endocytosis on TOR signaling. Partial reduc-
tion in Hsc70-4 levels lead to an increase in TOR signaling, as 
was evident in the eyTOR interaction and   rapamycin resistance. 
In contrast, larvae that are homozygous mutant for Hsc70-4 
show a decrease in TOR kinase activity. These results suggest 
that modest inhibition of endocytosis may increase TOR signal-
ing, whereas a complete block of endocytosis may reduce it.
A striking parallel to the inverse regulation of bulk and tar-
geted endocytic processes by TOR can be observed in its   effects 
on autophagy in yeast. Through autophagy, random portions of 
cytoplasm are nonselectively engulfed within double membrane–
bound vesicles for delivery to the lysosome. Activation of TOR 
causes this nonselective form of autophagy to be suppressed, 
and, instead, the autophagic machinery engages in a selective 
type of autophagy known as the cytoplasm–vacuole targeting 
(CVT) pathway, which is responsible for lysosomal delivery of 
specifi  c hydrolases (Klionsky and Emr, 2000). Thus, TOR acts 
as a switch between selective and nonselective autophagy. TOR 
may also be involved in switching between clathrin-and caveolae/
raft-mediated endocytosis in higher eukaryotes. A genome-wide 
survey of protein kinases found that RNAi-mediated inactiva-
tion of TOR in HeLa cells inhibited clathrin-dependent processes 
such as transferrin uptake and vesicular stomatitis virus infection, 
and stimulated cavelolae/raft-dependent events (Pelkmans et al., 
2005). Together, these fi  ndings suggest that TOR may control the 
specifi  city of membrane traffi  cking components. In addition, our 
results show that S6K, which is an important TOR substrate, acts 
downstream of TOR in promoting bulk endocytosis, but is not 
involved in the suppression of starvation-induced autophagy.
The identifi   cation of endocytosis as a TOR-controlled 
function adds to the growing list of cell processes regulated by 
TOR, including protein synthesis, ribosome biogenesis, auto-
phagy, metabolic gene expression, and cytoskeletal organization. 
How these distinct functions interact to achieve a coordinated 
growth response is only beginning to be understood. One likely 
mechanism involves the common use of molecular components 
and cellular substrates by different cell functions, as in the case 
of selective and nonselective autophagy, bulk endocytosis, and 
endocytic degradation. Two or more distinct branches of TOR 
signaling may also act cooperatively to control the same target, 
as in the case of Slimfast regulation by both translation and 
  endocytosis, or may act in opposition, as previously observed 
for the role of S6K in limiting autophagy. Finally, distinct TOR 
complexes may converge on the same targets with opposing 
  effects, as in the regulation of Akt by TOR-raptor versus TOR–
rictor complexes (Shah et al., 2004; Sarbassov et al., 2005b). 
The fi  nding that TOR signaling regulates the levels of Slimfast, 
which was previously shown to function upstream of TOR, adds 
another layer of complexity to the TOR signaling network.
Materials and methods
D. melanogaster genetics and culture
Strains used were as follows: dpp-lacZ
BS3.0, Hrs
D28, Hsc70-4
54.1, Hsc70-
4
∆16,  Hsc70-4
e195,  Hsc70-4
Wee-P1,  P[w
+]Hsc70-4.14,  S6k
l1, slif
1,  Tor
∆P, 
Figure 7.  Inverse regulation of bulk endocytosis 
and targeted endocytic degradation. (A) Under 
conditions favorable for growth, TOR promotes 
bulk endocytic uptake and   inhibits the endocytic 
turnover of speciﬁ   c nutrient importers such as 
Slimfast. (B) In growth-  inhibitory conditions, inac-
tivation of TOR leads to a decrease in bulk endo-
cytosis and an increase in the targeted endocytic 
degradation of excess nutrient importers. (C) To-
gether, the opposing actions of TOR on bulk and 
targeted endocytosis serve to facilitate nutrient 
import, providing energy and building blocks 
necessary for biosynthetic growth and leading 
to a further stimulation of TOR signaling.JCB • VOLUME 173 • NUMBER 6 • 2006  972
Tsc1
29, UAS-EGFP-Clc, UAS-Hsc4
K71S, UAS-Nedd4
C974FS, UAS-GFP-Rab5, 
UAS-Rab5
S43N,  UAS-GFP-Rab7,  UAS-Rheb
EP50.084,  UAS-shi
K44A,  UAS-slif, 
UAS-Tor,  UAS-Tsc1,  UAS-Tsc2,  UAS-4EBP,  Act>CD2>GAL4 UAS-GFP, 
Act>CD2>GAL4 UAS-myrRFP,  Cg-GAL4.A2,  en-GAL4,  fb-GAL4, 
MS1096-GAL4, and ey-FLP; FRT82B Pw
+ l(3)cl
R3. Flies were incubated at 
25°C on standard cornmeal–yeast medium, unless otherwise indicated. 
Starvation experiments were performed essentially as previously described 
(Scott et al., 2004). In brief, larvae were transferred to fresh ﬂ  y food sup-
plemented with yeast paste, allowed to feed for 24 h, and then transferred 
to a 20% sucrose solution and starved for the indicated time before dissec-
tion. For rapamycin treatment, larvae were cultured in standard ﬂ  y medium 
supplemented with 2 μM rapamycin.
Generation of eyTOR ﬂ  ies
A 1.5-kb KpnI (blunted)–BamHI fragment containing four copies of the 
eye-speciﬁ  c enhancer fragment from the ey gene and the noninducible 
hsp70 promoter was isolated from pBD1915 (Newsome et al., 2000), 
and ligated into the unique SalI (blunted) and XbaI sites located immedi-
ately upstream of a FLAG-tagged D. melanogaster Tor cDNA in pBlue-
script (Zhang et al. 2000). The ey-hsp70-Tor sequence was excised as a 
9.3-kb XbaI–PspOMI fragment and cloned into the transformation vector 
pCasper4 digested with XbaI and NotI. P element–mediated transposi-
tion was used to introduce the eyTOR transgene into yw ﬂ  ies by standard 
methods. CyO and TM3 balancers carrying eyTOR insertion lines were 
created through transposase-mediated mobilization of an X chromosome 
eyTOR insert.
Mutagenesis, mapping, and sequencing
Mutagenesis. yw males isogenized for the second and third chromosomes 
were starved for 2 h before being fed a solution of 25 mM EMS in 0.01 M 
Tris, pH 7.5, and 1% sucrose overnight. Batches of 50 mutagenized males 
were then mated to 50 CyO-eyTOR/Sp virgins. Crosses were reared in 
bottles at 25°C, being transferred once daily for 4 d before adults were 
discarded. F1 progeny were screened for the dominant enhancement or 
suppression of the eyTOR small eye phenotype. Flies carrying EMS-induced 
eyTOR-modifying mutations were back crossed to CyO-eyTOR and TM3-
eyTOR stocks, allowing mutations to be recovered and mapped to chromo-
some through segregation of the eyTOR interaction phenotype against the 
second and third chromosome markers.
Mapping. e3 and e19 were localized to map position 57 centi-
morgans on the third chromosome by genetic recombination, and this 
region was further reﬁ   ned to the 87E8-88E6 interval by deﬁ   ciency 
mapping. In complementation tests against available lethal mutations 
in this region, e3 failed to complement multiple P element-, EMS-, and 
x-ray–induced mutations in Hsc70-4. e19 showed complete failure to 
complement  e3 and Hsc70-4
54.1, which is an antimorphic allele of 
Hsc70-4, and partial complementation with other Hsc70-4 alleles. 
Based on this pattern of complementation and on the strength of eyTOR 
interactions, we classify e3 as an antimorph and e19 as a hypomorphic 
allele of Hsc70-4.
Sequencing e3 and e19 mutations. Genomic DNA was isolated 
from e3 and e19 homozygous mutant larvae, and the second exon of 
Hsc70-4 (containing the coding region) was PCR ampliﬁ  ed using the primers 
C  C  A  T  T  T  T  C  T  C  A  G  T  A  T  T  A  C  T  T  C  T  C  C  T  C  T  G  G  C   and G A  G  A  A  C  T  G  T  T  A  C  T  G  T  A  T  G-
G  T  T  G  C  A  T  T  G  A  G  G   and sequenced using the primers C  G  A  G  A  A  A  A  G  G  A  A-
A  A  T  T  A  G  A  A  T  T  G  T  A  A  A  A  C  A  C  A  C  C  , G  G  A  G  A  T  C  T  C  T  T  C  G  A  T  G  G  T  G  C  T  T  A  C  C  , 
C  A  A  G  C  A  C  A  A  G  A  A  G  G  A  T  C  T  G  A  C  C  A  C  C  , C  A  T  T  C  T  G  C  A  C  G  G  C  G  A  C  A  A  G-
T  C  G  , and G  T  C  G  T  C  T  C  T  C  C  A  A  G  G  A  G  G  A  C  A  T  C  .
Overexpression and loss-of-function clones in D. melanogaster 
fat body tissue
Gain-of-function clones. Clonal transgene expression was achieved using 
the Gal4-UAS system. Act>CD2>GAL4, UAS-GFP or Act>CD2>GAL4, 
UAS-myrRFP virgins were crossed to males carrying hs-FLP and UAS-driven 
transgenes of interest. FLP-mediated excision of the CD2 insert is induced 
spontaneously in  10% of fat body cells at 25°C, leading to Act5c-driven 
constitutive Gal4 expression in GFP- or myrRFP-marked single cells or small 
clones (Britton et al., 2002). GFP-Rab5 expressing cells were generated 
as above but in the absence of UAS-GFP.
Loss-of-function fat body clones. hs-FLP/FRT–mediated mitotic 
  recombination was induced in 0–8 h embryos, before initiation of 
  endoreplication in fat body tissue, through a 2 h, 37°C heat shock in 
an air incubator. For uniform GFP marker expression, the fat body drivers 
Cg-Gal4 or fb-Gal4 were used to activate UAS-GFP lines on FRT-bearing 
chromosomes. Loss-of-function clones were marked by the absence 
of GFP.
Histology
Fixation. Third instar larvae were dissected in PBS, inverted, and   transferred to 
1.5-mL tubes containing 3.7% formaldehyde in PBST (PBS + 0.1% Tween 20) 
for 4-h (imaginal discs) or overnight (fat body) ﬁ  xation at 4°C, with gentle 
agitation. Fix was removed through four 5-min washes in PBST.
Antibody staining. Fixed carcasses were blocked for 2–4 h in   PBSTG 
(PBST + 5% normal goat serum) before incubation in PBSTG + primary 
antibody at 4°C overnight. Carcasses were washed four times for 20 min 
in PBST and blocked in PBSTG for 1–2 h before incubation in PBST + 
  secondary antibody + 1 μM Hoechst 33258 at 4°C overnight. Carcasses 
were rinsed in PBST four times for 20 min. Tissue was dissected in PBS and 
mounted in FluoroGuard reagent (Bio-Rad Laboratories).
Antibodies. Anti-Slimfast (1:400 dilution of rabbit polyclonal sera 
raised against a bacterially produced fusion between GST and the COOH-
terminal cytoplasmic tail of Slif [amino acids 554–604]), anti-FOXO 
#3015 (1:300; gift from O. Puig, University of California, Berkeley, Berke-
ley, CA), anti-FLAG M5 (1:500; Sigma-Aldrich), anti-Elav 9F8A9 (1:50; 
Developmental Studies Hybridoma Bank), anti B-gal (1:500; Calbiochem), 
anti InR 386 (1:2,000; gift from R. Fernandez, New York University Medi-
cal Center, New York, NY), anti-Lsp2 (1:500; gift from H. Benes, University 
of Arkansas, Little Rock, AR).
Phalloidin staining. Carcasses were dissected, ﬁ  xed, washed, and 
blocked for 2–4 h in PBSTG, before being incubated at 4°C overnight in 
0.165 μM Alexa Fluor 568 phalloidin (Invitrogen) in PBSTG containing 
1  μM Hoechst 33258. Carcasses were rinsed in PBST four times for 
20 min before ﬁ  nal dissection, mounting, and imaging.
Live tissue staining. Lysotracker staining was performed as in Scott 
et al. (2004). For acridine orange staining, dissected eye discs were incu-
bated in PBS containing 1 μM acridine orange for 5 min at room temperature. 
Tissue was rinsed in PBS, transferred to a drop of PBS on a microscope 
slide, and covered loosely with a coverslip for imaging.
Endocytic uptake assay
5–10 larvae per genotype were bisected and inverted in PBS, and then 
transferred to a 1.5-mL tube containing 80 μg/ml TR-avidin (Invitrogen) 
in M3 insect medium (Sigma-Aldrich) containing 5% fetal calf serum, 
1× insect medium supplement (Sigma-Aldrich) and penicillin/streptomycin 
antibiotics (Invitrogen). Carcasses were incubated for 15 min at room 
  temperature with gentle agitation, rinsed two times and washed three times 
for 5 min with ice-cold PBS + 0.5% BSA at 4°C, and then ﬁ  xed, washed, 
and mounted in FluoroGuard Reagent.
Microscopy
Confocal images were acquired on a microscope (Axioplan 2; Carl 
Zeiss MicroImaging, Inc.) equipped with a digital camera (ORCA-ER; 
Hamamatsu) and a spinning disc confocal system (CARV; BD Biosciences). 
Axiovision v3.1 acquisition software, Plan-Apochromat 63×, 1.40 NA, 
and Plan-Neoﬂ  uar 40×, 0.75 NA, objectives were also used (all from Carl 
Zeiss MicroImaging, Inc.). All other images were taken with a digital camera 
(DXM1200; Nikon) attached to an epiﬂ  uorescence microscope (Axio-
scope 2; Carl Zeiss MicroImaging, Inc; ACT-1 acquisition software [Nikon], 
Plan-Neoﬂ  uar 40×, 0.75 NA, 20×, 0.50 NA, and 5×, 0.15 NA, objec-
tives were also used) or a digital camera (Coolpix 990; Nikon) attached 
to a dissecting microscope (Stemi 200C; Carl Zeiss MicroImaging, Inc.). 
All images were processed in Photoshop v7.0 (Adobe).
Scanning electron microscopy. Whole ﬂ  ies were passed through an 
ethanol series to achieve hydration in 100% EtOH. Flies were then dehy-
drated using a critical point dryer (model 780A; Tousimis), mounted on 
carbon tape, and gold sputter–coated using a high vacuum deposition 
system (DV-502A; Denton). Eyes were imaged using a Field Emission 
Gun Scanning Electron Microscope (S-4700; Hitachi; FE-PC SEM v3.3 
control software, v2.10 operating software) and transferred to PCI v4.2 
(Quartz) for processing.
Western blotting
Larvae were transferred to fresh medium supplemented with yeast paste 
and allowed to feed for 24 h before extraction. Extracts were prepared 
by homogenizing equal masses of wild-type or mutant larvae directly in 
1× SDS sample buffer. Extracts were boiled, run on an 8% SDS-polyacryl-
amide gel, and transferred to PVDF membrane using the Mini PROTEAN 3 
electrophoresis and wet transfer system (Bio-Rad Laboratories). Membranes 
were blocked in PBST containing 5% dry milk for 4 h before overnight 
  incubation in primary antibody. Primary antibodies were diluted in PBST 
containing 5% BSA. The primary antibodies used were as follows: Akt, 
P-Ser505-dAkt, P-Thr398-dS6K (1:1,000; Cell Signaling Technology), TOR REGULATES ENDOCYTOSIS TO EFFECT CELL GROWTH • HENNIG ET AL. 973
dS6K (1:1,000, mouse monoclonal; gift from G. Thomas, University of 
Cincinnati, Cincinnati, OH), dTOR (1:1,000; gift from D. Pan, Johns 
  Hopkins University, Baltimore, MD), tubulin DMIA (1:5,000; Calbiochem). 
Membranes were washed four times for 20 min in PBST and blocked 
for 1 h before 4 h incubation in HRP-conjugated secondary antibody. 
Membranes were washed four times for 20 min in PBST. SuperSignal ECL 
  substrate solutions (Pierce) were applied to membranes to allow protein 
detection on BioMax light ﬁ  lm (Kodak).
Flow cytometry
Mitotic loss-of-function clones were induced at 3.5 d after laying through 
a 2-h heat-shock in a 37°C air incubator, and were allowed to grow for 
45 h postinduction at room temperature. Overexpression clones were 
  induced at 3.5 d after laying through a 1 h 15-min heat-shock, and were 
allowed to grow for 48 h at 25°C. Approximately 25 wing imaginal discs 
per genotype were dissected and processed for FACS analysis, essentially 
as previously described (Neufeld et al., 1998). In brief, discs were added 
to 250 μL of PBS in 5 mL polystyrene round-bottom tubes, and kept on ice 
until 275 μL trypsin solution (9× Trypsin-EDTA [Sigma-Aldrich], 1× PBS, 
and 2 μM Hoechst 33342) was added to each tube to allow tissue dissocia-
tion into single cells. Samples were mixed on a Nutator (Clay Adams) 
at room temperature for a minimum of 2 h before ﬂ  ow cytometric analysis 
  using a FACSAria (BD Biosciences). FlowJo v4.4 was used for data analysis.
Online supplemental material
Fig. S1 displays additional effects of TOR overexpression in eye and 
wing tissues, interactions with additional Hsc70-4 alleles, and rescue by 
a genomic Hsc70-4 construct. Fig. S2 displays additional TR-avidin and 
Lsp2 internalization experiments. Fig. S3 shows Slimfast antibody speci-
ﬁ   city controls and additional Slimfast and insulin receptor localization 
data. Fig. S4 displays effects of Hsc70-4 on autophagy induction and 
cell size. Online supplemental material is available at http://www/jcb.
org/cgi/content/full/jcb.200511140/DC1.
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